Notify me when Vifor (International) Ltd files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CARA | Cara Therapeutics, Inc. | Common Stock, par value $0.001 per share | 13.5% | $2.46M | 7.4M | Vifor (International) Ltd. | 17 Dec 2024 | ||
| Tvardi Therapeutics, Inc. (formerly, Cara Therapeutics, Inc.) | Common Stock, par value $0.001 per share | 2.2% | 205K | Vifor (International) Ltd. | 15 Apr 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|